Ulobetasol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(6α,11β,16β)-21-chloro-6,9-difluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a601060 |
| Identifiers | |
| CAS Number |
98651-66-2 |
| ATC code | D07AC21 (WHO) |
| PubChem | CID 5311167 |
| ChemSpider |
4470691 |
| UNII |
9P6159HM7T |
| KEGG |
D08660 |
| ChEMBL |
CHEMBL1201360 |
| Synonyms | (6S,8S,9S,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
| Chemical data | |
| Formula | C22H27ClF2O4 |
| Molar mass | 428.897 |
| |
| |
| | |
Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis. It is a group I corticosteroid under the US classification, the most potent class of such drugs. Halobetasol propionate is usually supplied as a 0.05% topical cream.
External links
- halobetasol at the US National Library of Medicine Medical Subject Headings (MeSH)
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
